MINI REVIEW
Accepted on 02 Jul 2025
Emerging B and Plasma Cell-Targeting Immune Therapies in Idiopathic Inflammatory Myopathies
doi 10.3389/fimmu.2025.1581323
- 152 views
- Frontiers in Neurology
- Neurological Biomarkers
- Research Topics
- Autoantibodies and autoimmune neuromuscular disorders
Autoantibodies and autoimmune neuromuscular disorders
2,988
Total downloads
17k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 17 Apr 2025
Efgartigimod as a fast-acting treatment in generalized very-late-onset myasthenia gravis
doi 10.3389/fimmu.2025.1579859
- 1,698 views
ORIGINAL RESEARCH
Published on 24 Mar 2025
Telitacicept as an alternative to non-steroidal immunosuppressive therapies in the treatment of myasthenia gravis: a study on clinical efficacy and steroid-sparing effect
doi 10.3389/fimmu.2025.1549034
- 1,817 views
CORRECTION
Published on 12 Feb 2025
Corrigendum: Applicability of a serodiagnostic line blot for idiopathic inflammatory myopathy: the muscle biopsy is not all
doi 10.3389/fneur.2025.1567315
- 616 views
ORIGINAL RESEARCH
Published on 06 Jan 2025
Applicability of a serodiagnostic line blot for idiopathic inflammatory myopathy: the muscle biopsy is not all
doi 10.3389/fneur.2024.1504260
- 7,062 views
- 1 citation
CASE REPORT
Published on 07 Oct 2024
Case report: target antigen and subclass switch in a patient with autoimmune nodopathy
doi 10.3389/fimmu.2024.1475478
- 1,404 views
ORIGINAL RESEARCH
Published on 13 Sep 2024
Exhausted signature and regulatory network of NK cells in myasthenia gravis
doi 10.3389/fimmu.2024.1397916
- 2,129 views
- 1 citation
Published in
Frontiers in Neurology
Neurological Biomarkers
Participating Journals
Frontiers in Immunology
- 5.9 impact factor
- 10.8 citescore